Maprotiline is a tricyclic antidepressant that is used to treat depression. It works by blocking the reuptake of certain neurotransmitters in the brain such as norepinephrine and serotonin. This increases the levels of these neurotransmitters available for use by the brain, leading to an improvement in mood. Maprotiline may also be used to treat anxiety, panic disorder, and obsessive-compulsive disorder.
Maprotiline is a medication used to treat depression and some other conditions. Here's a breakdown of its key points:
Type of medication:
- Primarily classified as a tetracyclic antidepressant (TeCA), but can also be categorized as a tricyclic antidepressant (TCA), specifically a secondary amine TCA.
Conditions treated:
- Depression, particularly when accompanied by agitation or anxiety. Studies show it has similar effectiveness to other antidepressants like moclobemide.
- Bipolar disorder
- Anxiety associated with depression
- Neuropathic pain, including diabetic and non-diabetic painful polyneuropathy (nerve damage causing pain)
How it works:
- Exact mechanism is not fully understood, but it likely works by affecting brain chemicals involved in mood regulation.
- Key mechanism involves inhibiting the reuptake of norepinephrine, a brain chemical that helps nerve cells communicate.
- Unlike some TCAs, it doesn't appear to directly affect serotonin reuptake.
Things to consider:
- Maprotiline may have side effects similar to other TCAs, including dry mouth, constipation, drowsiness, and dizziness.
- It can interact with other medications, so it's important to tell your doctor about all the medications you're taking before starting maprotiline.
- Due to its effect on certain brain chemicals, it can lower the seizure threshold, meaning it might increase the risk of seizures in some people.
Anatomical Therapeutic Chemical Classification
N - Nervous system
N06 Psychoanaleptics
N06A - Antidepressants
N06AA Non-selective monoamine reuptake inhibitors
ATC Code
External Links
Maprotiline